(Q46648565)

23 December 2017

title

NS-398, a selective cyclooxygenase-2 inhibitor, reduces experimental bladder carcinoma outgrowth by inhibiting tumor cell proliferation (English)

1 reference

23 December 2017

1 reference

Niels Smakman

1

1 reference

23 December 2017

Nicoline Schaap

2

1 reference

23 December 2017

Cristel M J T Snijckers

3

1 reference

23 December 2017

Inne H M Borel Rinkes

4

1 reference

23 December 2017

Onno Kranenburg

5

1 reference

23 December 2017

language of work or name

English

0 references

publication date

1 August 2005

1 reference

23 December 2017

published in

Urology

1 reference

23 December 2017

volume

66

1 reference

23 December 2017

page(s)

434-440

1 reference

23 December 2017

issue

2

1 reference

23 December 2017

Targeting cyclooxygenase-2 in human neoplasia: rationale and promise

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2005.02.024

Cyclooxygenase-2 as a potential target in the prevention and treatment of genitourinary tumors: a review

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2005.02.024

Association of cyclooxygenase-2 expression with prognosis of stage T1 grade 3 bladder cancer.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2005.02.024

Piroxicam therapy in 34 dogs with transitional cell carcinoma of the urinary bladder

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2005.02.024

Enhanced expression of cyclooxygenase-2 in high grade human transitional cell bladder carcinomas

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2005.02.024

Expression of cyclooxygenase-2 in human transitional cell carcinoma of the urinary bladder

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2005.02.024

Cyclooxygenase-2 is highly expressed in carcinoma in situ and T1 transitional cell carcinoma of the bladder

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2005.02.024

Correlation of cyclooxygenase-2 expression with molecular markers, pathological features and clinical outcome of transitional cell carcinoma of the bladder

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2005.02.024

Relation between cyclooxygenase-2 expression and tumor invasiveness and patient survival in transitional cell carcinoma of the urinary bladder.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2005.02.024

Cyclooxygenase 2 inhibitors: discovery, selectivity and the future

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2005.02.024

NS-398, a novel non-steroidal anti-inflammatory drug with potent analgesic and antipyretic effects, which causes minimal stomach lesions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2005.02.024

Non-steroidal anti-inflammatory drugs and bladder cancer prevention

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2005.02.024

Cyclooxygenase-2: a novel target for cancer chemotherapy?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2005.02.024

Regulating c-Ras function. cholesterol depletion affects caveolin association, GTP loading, and signaling

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2005.02.024

Validation of bioluminescence imaging of colorectal liver metastases in the mouse

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2005.02.024

Cyclooxygenase-2 promotes angiogenesis in pTa/T1 urothelial bladder carcinoma but does not predict recurrence.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2005.02.024

A histopathologic investigation of PGE(2) pathways as predictors of proliferation and invasion in urothelial carcinomas of the bladder

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2005.02.024

Multiple roles of COX-2 in tumor angiogenesis: a target for antiangiogenic therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2005.02.024

Prognostic value of the proliferative index determined by Ki-67 immunostaining in superficial bladder tumors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2005.02.024

10.1016/J.UROLOGY.2005.02.024

7 January 2021

Identifiers

DOI

1 reference

23 December 2017

PubMed ID

16098373

1 reference

23 December 2017